Removal of cardiac AL amyloid with positive remodelling of cardiomyocytes and of restrictive cardiomyopathy

ESC Heart Fail. 2022 Dec;9(6):4330-4334. doi: 10.1002/ehf2.14017. Epub 2022 Sep 3.

Abstract

Herein, we describe histological mobilization of light chain cardiac amyloid documented by sequential left ventricular endomyocardial biopsies. These findings were associated with positive remodelling of cardiomyocytes and of restrictive cardiomyopathy resulting from 14 courses of chemotherapy over 17 years of time. Histological and ultrastructural findings of light chain cardiac amyloid removal led to increase in cardiomyocyte dimension and electrocardiogram voltages, reduction of biventricular wall thickness with improvement of left ventricular diastolic function, and NYHA class shifting from III to I.

Keywords: Cardiac AL amyloid; Remodelling; Restrictive cardiomyopathy.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amyloid / metabolism
  • Biopsy
  • Cardiomyopathy, Restrictive* / diagnosis
  • Cardiomyopathy, Restrictive* / metabolism
  • Humans
  • Myocardium / pathology
  • Myocytes, Cardiac / metabolism

Substances

  • Amyloid